热搜词：
注册
登录
CN
  • CN
  • EN

产品中心 细胞因子 生长因子

所有图片（1/1）

FGF-12 Protein, Human

Fibroblast growth factor homologous (FHF-1),Myocyte-activating factor,FGF12B

价格 ￥620.00 （ 供应商现货 ： 3-5个工作日）
货号 UA040116
规格
数量
收藏 分享
产品介绍

产品介绍 评论(0)

产品规格

  • 物种

    Human

  • 抗原名称

    FGF-12

  • 分子别名

    Fibroblast growth factor homologous (FHF-1), Myocyte-activating factor, FGF12B

  • Accession

    P61328-2

  • 表达序列

    Met1-Thr181

  • 表达宿主

    E.coli

  • 分子量

    21kDa

  • 纯度

    ＞95% by SDS-PAGE

  • 内毒素含量

    <0.1EU/μg

  • 标记

    Unconjugated

  • 标签

    No Tag

  • 性状

    Lyophilized Powder

  • 缓冲体系

    20mM PB, 150mM NaCl, 1mM DTT, 1mM EDTA, pH 7.4

  • 溶解方法

    Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.

  • 储存条件

    · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.

    · 3 months, -20 to -80℃ under sterile conditions after reconstitution.

    · 1 week, 2 to 8℃ under sterile conditions after reconstitution.

    · Please avoid repeated freeze-thaw cycles.

  • 文献引用

    1. Am J Physiol Heart Circ Physiol. 2015 Jun 15;308(12):H1463-73.

背景介绍

  • Fibroblast growth factor 12 (FGF-12), also known as fibroblast growth factor homologous factors (FHF), is cytosolic proteins that is homologous to fibroblast growth factors but is not secreted. FGF12 modulates both cardiac Na+ and Ca+ channel by binding to the conserved proximal part of the C-terminal domain of voltage-gated sodium channels Nav1.5. However, a single missense mutation in FGF12-B (Q7R-FGF12) reduced binding to the NaV1.5 C-terminus, yielding a Brugada Syndrome phenotype.

  • 电泳

    • 1μg (R: reducing condition, N: non-reducing condition).

评论(0)